1. Chen F, Jin JY, Hui TSK, Jing H, Zhang H, Nong Y, Han Y, Wang W, Ma L, Yi F, Chen Q, Zhang Y, Fu P, Yang L, Xu Z, Kong FS.Radiation Induced Lymphopenia Is Associated With the Effective Dose to the Circulating Immune Cells in Breast Cancer.Front Oncol.2022. .10.3389/fonc.2022.768956..SCI |
2. JIN .Prospect of radiotherapy technology development in the era of immunotherapy.Journal of the National Cancer Center, .2022. 2(2).106-112.SCI |
3. Yu H, Chen F, Lam KO, Yang L, Wang Y, Jin JY, Ei Helali A, Kong FS..Potential Determinants for Radiation-Induced Lymphopenia in Patients With Breast Cancer Using Interpretable Machine Learning Approach..Front Immunol.2022. .10.3389/fimmu.2022.768811.SCI |
4. Yu Y, Fu P, Jin JY, Gao S, Wang W, Machtay M, Wang L, Kong FS, Yu J.Impact of effective dose to immune cells (EDIC) on lymphocyte nadir and survival in limited-stage SCLC.Radiother Oncol..2021.162.26-33.SCI |
5. Yuan J, Fredman E, Jin JY, Choi S, Mansur D, Sloan A, Machtay M, Zheng Y.Monte Carlo Dose Calculation Using MRI Based Synthetic CT Generated by Fully Convolutional Neural Network for Gamma Knife Radiosurgery.Technol Cancer Res Treat..2021. .doi: 10.1177/1533033821104643.SCI |
6. Chen F, Yu H, Zhang H, Nong Y, Wang Q, Jing H, Han Y, Wu J, Zhou Z, Yang L, Xu Z, Liu Y, Fu P, Jin JY, Hsue V, Chang A, Kong FS.Risk factors for radiation induced lymphopenia in patients with breast cancer receiving adjuvant radiotherapy.. Ann Transl Med.2021.9(16).1288.SCI |
7. Jin JY, Hu C, Xiao Y, Zhang H, Paulus R, Ellsworth SG, Schild SE, Bogart JA, Dobelbower MC, Kavadi VS, Narayan S, Iyengar P, Robinson C, Greenberger JS, Koprowski C, Machtay M, Curran W, Choy H, Bradley JD, Kong FS.Higher Radiation Dose to the Immune Cells Correlates with Worse Tumor Control and Overall Survival in Patients with Stage III NSCLC: A Secondary Analysis of RTOG0617..Cancers (Basel)..2021.13(24).6193,10.3390/cancers13246193.SCI |
8. Jin JY, Gu A, Wang W, Oleinick NL, Machtay M, Kong FM(S).Ultra-High Dose Rate Effect on Circulating Immune Cells: A Potential Mechanism for FLASH Effect?.Radiother Oncol..2020.149.55-62.SCI |
9. Wang W, Matuszak MM, Hu C, Huang KC, Chen E, Arenberg D, Curtis JL, Jolly S, Jin JY, Machtay M, Ten Haken RK, Kong F-MS:.Central Airway Toxicity After High Dose Radiation: A Combined Analysis of Prospective Clinical Trials for Non-Small Cell Lung Cancer.Int J Radiat Oncol Biol Phys..2020.108(3).587-596.SCI |
10. So TH, Chan SK, Chan WL, Choi H, Chiang CL, Lee V, Lam TC, Wong I, Law S, Kwong D, Ming Spring Kong F, Jin JY, Lam KO.Lymphopenia and radiation dose to circulating lymphocyte with neoadjuvant chemoradiation in esophageal squamous cell carcinoma.Advances in Radiation Oncology .2020.5(5).880-888.SCI |
11. Ellsworth SG, Yalamanchali A, Zhang H, Grossman SA, Hobbs R, Jin JY..Comprehensive Analysis of the Kinetics of Radiation-Induced Lymphocyte Loss in Patients Treated with External Beam Radiation Therapy.Radiat Res.2020.193(1).73-81..SCI |
12. Liu Y, Wang W, Shiue K, Yao H, Cerra-Franco A, Shapiro RH, Huang KC, Vile D, Langer M, Watson G, Bartlett G, Ai H, Sheski F, Jin JY, Zellars R, Fu P, Lautenschlaeger T, Kong FS..Risk factors for symptomatic radiation pneumonitis after stereotactic body radiation therapy (SBRT) in patients with non-small cell lung cancer..Radiother Oncol..2020.156.231-238.SCI |
13. Yalamanchali A, Zhang H, Huang KC, Mohan R, Lin SH, Zhu C, Grossman SA, Jin JY, Ellsworth S, .Patient-Specific Lymphocyte Loss Kinetics as Biomarker of Spleen Dose in Patients Undergoing Radiation Therapy for Upper Abdominal Malignancies.Advances in Radiation Oncology .2020.6(1).100545.SCI |
14. Yu H, Lam KO, Wu H, Green M, Wang W, Jin JY, Hu C, Jolly S, Wang Y, Kong FS.Weighted-Support Vector Machine Learning Classifier of Circulating Cytokine Biomarkers to Predict Radiation-Induced Lung Fibrosis in Non-Small-Cell Lung Cancer Patients.Front Oncol.2020. . DOI: 10.3389/fonc.2020.601979.SCI |
15. Xu C, Jin JY, Zhang M, Liu A, Wang J, Mohan R, Kong FS, Lin SH.The impact of the effective dose to immune cells on lymphopenia and survival of esophageal cancer after chemoradiotherapy..Radiother Oncol..2020.146.180-186.SCI |
16. Yu H, Wu H, Wang W, Jolly S, Jin JY, Hu C, Kong FS.Machine Learning to Build and Validate a Model for Radiation Pneumonitis Prediction in Patients with Non-Small Cell Lung Cancer..Clin Cancer Res.2019.25(14).4343-4350.SCI |
17. 20. Xue J, Han C, Jackson A, Hu C, Yao H, Wang W, Hayman J, Chen W, Jin J, Kalemkerian GP, Matuzsak M, Jolly S, Kong FS.Doses of radiation to the pericardium, instead of heart, are significant for survival in patients with non-small cell lung cancer..Radiother Oncol..2019.133.213-219.SCI |
18. Jin JY, Mereniuk T, Yalamanchali A, Wang W, Machtay M, Kong FM, Ellsworth S.A framework for modeling radiation induced lymphopenia in radiotherapy.Radiother Oncol.2019.144.105-113..SCI |
19. 21. Li L, Ma L, Shang D, Liu Z, Yu Q, Wang S, Teng X, Zhang Q, Hu X, Zhao W, Hou W, Jin J, Kong FS, Yu J, Yuan S.Pretreatment PET/CT imaging of angiogenesis based on (18)F-RGD tracer uptake may predict antiangiogenic response.Eur J Nucl Med Mol Imaging.2019.46(4).940-947.SCI |
20. Yuan J, Mansur D, Yao M, Biswas T, Zheng Y, Jesseph R, Jin JY, Machtay M.An Integrated Framework Based on Full Monte Carlo Simulations for Double-Scattering Proton Therapy.Int J Part Ther.2019.6(2).31-41.SCI |
21. Wang W, Huang L, Jin JY, Pi W, Ellsworth SG, Jolly S, Mellor AL, Machtay M, Kong FS.A Validation Study on IDO Immune Biomarkers for Survival Prediction in Non-small Cell Lung Cancer: Radiation Dose Fractionation Effect in Early Stage Disease..Clin Cancer Res.2019.26(1).282-289.SCI |